United States Food and Drug Administration (USFDA) has conducted an inspection at Jeevan Scientific Technology’s (JSTL) Bioanalytical Facility, at Manikonda, Hyderabad. The purpose of the inspection was to review the BA/BE studies as well as the operations, systems and procedures. The inspector started the review on February 20, 2024 and closed on February 23, 2024.
The inspector closed the inspection with no 483, i.e., no findings. The inspector concluded that the entire JSTL team is well trained, knowledgeable and experienced with International Regulatory requirements and Good practices, working within an adequately designed infrastructure and that the organization is compliant with all applicable regulations.
Jeevan Scientific Technology carries business clinical research and data management services.
